Observational Study
Copyright ©The Author(s) 2020.
World J Clin Cases. Dec 26, 2020; 8(24): 6306-6314
Published online Dec 26, 2020. doi: 10.12998/wjcc.v8.i24.6306
Table 3 Examination results of patients with or without early renal injury
Early renal injury groups
Normal group (n = 38)
Abnormal group (n = 31)
Age in yr55.8 ± 15.055.0 ± 11.9
Sex as M/F25/1323/8
Antiviral treatment time in mo99.3 ± 37.7104.1 ± 39.4
GGT as IU/L21.7 ± 11.337.2 ± 16.21
DBIL as µmol/L2.5 ± 1.53.5 ± 1.42
Creatinine as µmol/L81.0 ± 14.087.9 ± 14.53
BUN as mmol/L5.0 ± 1.25.4 ± 1.6
Cases of increased serum BUN2 (5.3%)3 (9.1%)
eGFR as mL/(min·1.73 m2)86.5 ± 15.380.7 ± 15.5
eGFR ≥ 90, n = 2214 (36.8%)8 (25.8%)
eGFR: 70-89, n = 4218 (47.4%)13 (41.8%)
eGFR: 60-69, n = 424 (10.5%)7 (22.6%)
eGFR: 30-59, n = 52 (5.3%)3 (9.7%)
UA as µmol/L314.2 ± 76.2338.8 ± 88.4
Serum calcium as mmol/L2.36 ± 0.102.35 ± 0.12
Serum phosphorus as mmol/L0.99 ± 0.160.97 ± 0.17
Cases of decreased serum phosphorus6 (15.8%)7 (22.6%)
Magnesium as mmol/L0.95 ± 0.070.97 ± 0.07
Urinary creatinine as mmol/L6.9 (2.5-20.3)12.4 (5.8-29.5)4
Urine microalbumin as mg/L4.0 (2-12.8)11.2 (2-123)5
NAG enzyme as U/L4.1 (1-12)10.4 (2-59)6
α1 microglobulin as mg/L4.9 (4-17.4)15.5 (4.68-158)7
Urinary immunoglobulin as mg/L3 (3-4.1)6.7 (3.14-29.3)8